{{Rsnum
|rsid=2107425
|Chromosome=11
|position=1999845
|Orientation=plus
|GMAF=0.4164
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 48.6 | 42.3 | 9.0
| HCB | 40.4 | 41.9 | 17.6
| JPT | 27.4 | 46.9 | 25.7
| YRI | 17.7 | 48.3 | 34.0
| ASW | 22.8 | 52.6 | 24.6
| CHB | 40.4 | 41.9 | 17.6
| CHD | 37.6 | 54.1 | 8.3
| GIH | 29.7 | 47.5 | 22.8
| LWK | 12.8 | 46.8 | 40.4
| MEX | 27.6 | 41.4 | 31.0
| MKK | 15.5 | 54.8 | 29.7
| TSI | 47.5 | 46.5 | 5.9
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19543528
|Title=Association between Common Germline Genetic Variation in 94 Candidate Genes or Regions and Risks of Invasive Epithelial Ovarian Cancer
|OA=1
}}

{{PMID Auto
|PMID=20145138
|Title=Common genetic variants associated with breast cancer and mammographic density measures that predict disease
}}

{{PMID Auto
|PMID=21748294
|Title=Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes
}}

{{PMID Auto
|PMID=16839189
|Title=Human imprinted chromosomal regions are historical hot-spots of recombination.
|OA=1
}}

{{PMID Auto
|PMID=18224312
|Title=Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment.
|OA=1
}}

{{PMID Auto
|PMID=18262338
|Title=Polymorphisms in the H19 gene and the risk of bladder cancer.
}}

{{PMID Auto
|PMID=18681954
|Title=Breast cancer susceptibility loci and mammographic density.
|OA=1
}}

{{PMID Auto
|PMID=18708391
|Title=Breast cancer risk polymorphisms and interaction with ionizing radiation among U.S. radiologic technologists.
|OA=1
}}

{{PMID Auto
|PMID=19304784
|Title=Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study.
|OA=1
}}

{{PMID Auto
|PMID=19330030
|Title=A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).
|OA=1
}}

{{PMID Auto
|PMID=19639606
|Title=Correcting "winner's curse" in odds ratios from genomewide association findings for major complex human diseases.
|OA=1
}}

{{PMID Auto
|PMID=19936258
|Title=Epigenetic features of human mesenchymal stem cells determine their permissiveness for induction of relevant transcriptional changes by SYT-SSX1.
|OA=1
}}

{{PMID Auto
|PMID=20085711
|Title=Leveraging genetic variability across populations for the identification of causal variants.
|OA=1
}}

{{PMID Auto
|PMID=20159110
|Title=Allelic skewing of DNA methylation is widespread across the genome.
|OA=1
}}

{{PMID Auto
|PMID=22907587
|Title=IGF2 DNA methylation is a modulator of newborn's fetal growth and development.
|OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}